Latest Insights on NET
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Self-Driving Cars Are Coming: Invest Now for Huge Profits January 31, 2020 Investment Opportunities, Technology, Winning Investor Daily
Goldman Sachs believes self-driving cars will be a $7 trillion market. And that massive disruption is closer than most expect…
Fixing Our Broken Economy January 31, 2020 Big Picture. Big Profits., Economy, U.S. Economy
[17-minute video] The true conclusion of my series on anticompetitive practices in the U.S. 
Tesla’s Cash Flows; Verizon’s Crossroads; Facebook Erodes January 30, 2020 Great Stuff
Tesla to Bears: Eat My Shorts Do we have any Tesla Inc. (Nasdaq: TSLA) bears reading today? I know you’re out there. You write in to Great Stuff every time I say something positive about the company. Well, get your emails ready. Today, Tesla’s taking a victory lap … and I’m saying: “I told you […]
3,000-Year-Old Story Reveals the Secret to Stock Market Fortunes January 30, 2020 American Investor Today, Trading Strategies
When it comes to investing, it pays to root for the underdog. Charles Mizrahi shows you why unloved and unwanted stocks often possess huge advantages over their competition — and what we can learn from the 3,000-year-old story of David and Goliath. MEET OUR EXPERTS
Director of VIP Services
Research Analyst
Chief Investment Strategist of Money & Markets
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
